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Background: Toxoplasmosis is caused by the apicomplexan parasite Toxoplasma gondii and can be acquired either
congenitally or via the oral route. In the latter case, transmission is mediated by two distinct invasive stages, i.e.,
bradyzoites residing in tissue cysts or sporozoites contained in environmentally resistant oocysts shed by felids in
their feces. The oocyst plays a central epidemiological role, yet this stage has been scarcely investigated at the
molecular level and the knowledge of its expressed proteome is very limited.
Results: Using one-dimensional gel electrophoresis coupled to liquid chromatography-linked tandem mass
spectrometry, we analysed total or fractionated protein extracts of partially sporulated T. gondii oocysts, producing a
dataset of 1304 non reduntant proteins (~18% of the total predicted proteome), ~59% of which were classified
according to the MIPS functional catalogue database. Notably, the comparison of the oocyst dataset with the
extensively covered proteome of T. gondii tachyzoite, the invasive stage responsible for the clinical signs of
toxoplasmosis, identified 154 putative oocyst/sporozoite-specific proteins, some of which were validated by
Western blot. The analysis of this protein subset showed that, compared to tachyzoites, oocysts have a greater
capability of de novo amino acid biosynthesis and are well equipped to fuel the Krebs cycle with the acetyl-CoA
generated through fatty acid β-oxidation and the degradation of branched amino acids.
Conclusions: The study reported herein significantly expanded our knowledge of the proteome expressed by the
oocyst/sporozoite of T. gondii, shedding light on a stage-specifc subset of proteins whose functional profile is
consistent with the adaptation of T. gondii oocysts to the nutrient-poor and stressing extracellular environment.
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Oocyst-specific proteinsBackground
The obligate intracellular parasite Toxoplasma gondii is
a protozoan of the Phylum Apicomplexa highly preva-
lent in humans and animals worldwide [1]. Its clinical
relevance is mainly due to potential congenital trans-
mission to the fetus by seronegative women, causing
intrauterine death or severe sequelae in the newborn [2]
and adult life [3]. Furthermore, reactivation of latent in-
fections in immunocompromised subjects can lead to* Correspondence: furio.spano@iss.it
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reproduction in any medium, provided the orlife-threatening encephalitis. The complex life cycle of
T. gondii includes three infectious stages, the tachyzoite,
the bradyzoite and the sporozoite [4]. The rapidly divid-
ing tachyzoite is responsible for the clinical signs of
toxoplasmosis, as it disseminates the infection to virtu-
ally all organs and tissues of the host and can reach the
fetus transplacentally. However, the major role in dis-
ease transmission is played by the oral ingestion of ei-
ther bradyzoites encysted in the tissues of chronically
infected hosts or sporozoites contained in the oocyst.
This highly resistant environmental stage is the result of
sexual reproduction, which occurs in the intestinal epi-
thelium of cats and virtually all species of felids andl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Comparison between independent proteomic
experiments. The Venn diagram shows the number of unique and
shared oocyst/sporozoite proteins identified by LC-MS/MS in three
independent biological replicates. Experiments 1, 2 and 3 allowed to
identify 1083, 1082 and 1314 T. gondii proteins, respectively, with
overlaps among different experiments comprised between 65%
and 83%.
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cysts [5]. In the external environment, oocysts undergo
sporogony [6] and develop two ellipsoidal sporocysts
containing four infectious sporozoites each, which can
survive in moist soil or water for months to years [1].
Despite its crucial epidemiological role, the sporozoite is
the less characterized at the molecular level among the in-
fectious stages of T. gondii, mostly due to the difficulty in
producing and handling oocysts. The existence of oocyst/
sporozoite-specific proteins was first documented nearly
thirty years ago by serological and biochemical methods
[7,8], yet no stage-specific protein was identified until 2004,
when Radke and colleagues characterized the major sporo-
zoite surface antigen SRS28 (SporoSAG) [9]. Subsequently,
we reported on the cloning and immunolocalization of the
cysteine-rich oocyst wall proteins TgOWP1, TgOWP2 and
TgOWP3 [10], whereas Hill et al. [11] employed a
proteomic-based approach to demonstrate that sporozoites
specifically express the immunogenic embryogenesis-
related protein (TgERP). In recent years, several groups ap-
plied different high-throughput proteomic techniques to
the study of the tachyzoite of T. gondii. The analysis of
whole [12,13] or enriched [14-21] protein extracts provided
an extensive coverage of the protein complement expressed
by this parasite stage, with >5000 distinct proteins identi-
fied, which account for ~73% of the global predicted prote-
ome. Following large-scale proteomic analyses of the oocyst
stage of two other apicomplexans, i.e., Cryptosporidium
parvum [22,23] and Eimeria tenella [24], very recently Fritz
and co-workers published a proteomic study of fully sporu-
lated oocysts of the T. gondii strain M4 (genotype II) [25].
Using one-dimensional (1-D) gel electrophoresis coupled to
liquid chromatography (LC)-linked tandem mass spectrom-
etry (MS/MS), the authors analysed protein extracts from
either oocyst wall or sporocyst/sporozoite fractions and
produced a first proteomic chart of 1031 individual pro-
teins, including small subsets of molecules possibly impli-
cated in oocyst environmental resistance and moving
junction formation.
In the present work, we report on the proteomic analysis
of partially sporulated oocysts of T. gondii belonging to the
genotype III strain VEG. The identification of 1304 non re-
dundant proteins increased significantly the coverage of the
oocyst/sporozoite proteome and allowed to expand our
knowledge of developmentally regulated protein expression
in T. gondii, highlighting differences between the reper-
toires of metabolic enzymes expressed by the oocyst/sporo-
zoite and tachyzoite stage.
Results
Analysis of the oocyst/sporozoite proteome of T. gondii
by one-dimensional electrophoresis gel LC MS/MS
To shed light on the expressed proteome of the oocyst/
sporozoite of Toxoplasma gondii, total proteins wereextracted from partially sporulated oocysts of the type III
strain VEG [1] and analysed by one-dimensional gel elec-
trophoresis LC-MS/MS in three independent experiments
(Additional file 1). The oocyst batch used throughout the
study consisted of approximately 60% fully sporulated and
40% non sporulated oocysts, as estimated by light micros-
copy observation.
Peptide sequences generated from raw mass spectra
were initially matched against the release 5.1 of ToxoDB
(http://www.toxodb.org/), yielding 6114 individual protein
identifications. The entire dataset was successively
updated on the release 7.1 of the database. After removal
of redundancies, mostly due to multiple identifications of
the same gene in different parasite reference strains, ex-
periments 1, 2 and 3 allowed the identification of 1083,
1082 and 1314T. gondii proteins, respectively (Figure 1),
with overlaps between different experiments of between
65% and 83%. Approximately 47% of the proteins (758)
were identified in all experiments, whereas varying num-
bers were detected uniquely in experiment 1 (115), 2 (77)
or 3 (317) (Figure 1). The three independent analyses
yielded a combined dataset of 1615 non redundant oocyst/
sporozoite proteins (Additional file 2) accounting for ~22%
of the ToxoDB predicted proteome, which, according to a
recent estimate, consists of ~7300 proteins [26]. According
to ToxoDB annotations, 25% of the 1615 proteins identified
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least one transmembrane domain, two structural features
occurring in very similar proportions in the predicted
proteome of T. gondii, i.e., 21% and 18%, respectively. Ap-
proximately 38% of the oocyst/sporozoite identifications
correspond to “hypothetical” proteins, which otherwise ac-
count for nearly 60% of the entire predicted proteome.
Functional analysis of the protein dataset
Of 1615 proteins, 311 (19%) were identified with a single
peptide in one experiment and were excluded from func-
tional analyses. The remaining 1304 proteins were
assigned a subcellular localization (Figure 2A) combining
the Gene Ontology (GO) cellular component predictions
available in ToxoDB, with the results produced by the
general subcellular predictor WoLF PSORT. PutativeFigure 2 Predicted subcellular localization and functional classificatio
assigned a subcellular localization combining the results of the general pre
the identification of mitochondrial and apicoplast targeting signals, respect
to the MIPS functional catalogue database. Assignments were based on GO
of the KEGG Pathway database and on independent BLAST homology and
class is indicated.mitochondrial and apicoplast localizations were further
assessed using the PlasMit and PATS predictors, respect-
ively. Proteins with cytoplasmic (24%), nuclear (21%) and
mitochondrial (14%) localizations were highly represented,
whereas nearly one-third of the molecules identified
were associated with parasite’s secretory routes, including
those assigned to extracellular locations (14%), the
plasmamembrane (10%) and the apical complex (4%). The
latter category included 47 micronemal and rhoptry pro-
teins, many of which have been thoroughly characterized
in recent years.
Of 1304 proteins, 767 (~59%) were assigned a functional
category according to the MIPS functional catalogue data-
base (FunCatDB) (Figure 2B). The vast majority of these
proteins were classified using the GO biological process
annotations of ToxoDB, which cover only 25% of then of oocyst/sporozoite proteins. (A) The proteins identified were
dictor WoLF PSORT with those of the programs PlaMit and PATS for
ively. (B) Proteins were classified into functional categories according
biological process annotations provided by ToxoDB, on annotations
literature searches. NA, not assigned. The number of proteins in each
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volved in metabolic processes was identified using the
KEGG Pathway database (http://www.genome.jp/kegg/),
whereas approximately 80 molecules were assigned to a
MIPS category based on sequence similarities with func-
tionally characterized T. gondii paralogs, independent
BLAST homology searches or exploiting information on
subcellular localization contained in recent literature. The
most numerous functional categories included proteins in-
volved in protein fate (164), metabolism (140), protein
synthesis (101), cell rescue, defence and virulence (99) and
cellular transport (97).
The comparison of the VEG oocyst proteins with the
expressed tachyzoite proteome provided a global, yet not
exhaustive, view of the different protein repertoires ex-
pected to play a role in host cell invasion by T. gondii spo-
rozoites. Our dataset comprises 9 proteins belonging to the
SRS superfamily [27], which consists of >100 GPI-
anchored surface ligands related to SRS29B (SAG1), an
immunodominant protein highly expressed on tachyzoites.
We also detected 16 proteins (MICs) localized to theFigure 3 Comparison between proteomic and transcriptional data of
1304 oocyst proteins identified in this study and different types of transcrip
expression of 7114 T. gondii genes in sporulated oocysts of strain M4 [34]. E
sporozoite SAGE tags (≥2 counts, 1 occurrence/genome, sense) [33] of stra
prior to comparison with the proteomics and microarray datasets. (B) The h
identified in this study among various classes of mRNA microarray expressi
usporulated (day 0) versus sporulated (day 10) oocysts and vice versa. Were
fold increase ≥2 at day 0 or day 10, respectively. (C) Classification into MIPS
relative transcriptional upregulation ≥2 in day 0 or day 10 oocysts.micronemes, the apical secretory organelles involved in
parasite motility and/or invasion, and several invasion-
related molecules residing in a second type of apical organ-
elle, i.e., the club-shaped rhoptry [28]. These included 11
rhoptry neck proteins (RONs), which are essential constit-
uents of the moving junction [29,30], and 28 rhoptry bulb
proteins (ROPs), which are secreted into the nascent
parasitophorous vacuole (PV) or injected into the host cell
cytoplasm, thus participating in the modification of the PV
membrane or in the subversion of host cell transcription.
The oocyst dataset included also 8 proteins localized to the
dense granules (GRAs), which release their content into
the vacuolar space in the late phases of invasion [31].
Correlation between proteomic and transcriptional data
To gain insight into the relationship between protein
and mRNA expression [32], we matched the proteomic
data generated in the present study with oocyst/sporozo-
ite-specific transcriptional data available in ToxoDB 7.1
(Figure 3A). These included 1167 non redundant ESTs
from partially (999) or fully (250) sporulated oocysts,T. gondii oocysts. (A) Venn diagram showing the overlap between
tional data incorporated in ToxoDB 7.1. Microarray data refer to mRNA
STs from sporulated and unsporulated oocyst (1167) and 1269
in VEG were combined with each other to eliminate redundancies
istogram shows the distribution of 1304 T. gondii genes proteomically
on [34]. Numeric ranges indicate the fold increase of mRNA levels in
included in the analysis 248 and 393 genes showing a transcriptional
functional categories of the proteins encoded by genes exhibiting a
Possenti et al. BMC Genomics 2013, 14:183 Page 5 of 18
http://www.biomedcentral.com/1471-2164/14/1831269 non redundant sporozoite SAGE tags [33] and mRNA
microarray data on 7114T. gondii genes relative to M4
oocysts at various sporulation stages [34]. Using ToxoDB
bioinformatic tools, we analysed the M4 microarray data to
identify genes upregulated in day 0 (unsporulated) versus
day 10 (fully sporulated) oocysts and vice versa. Excluding
genes with a transcriptional fold increment <2, we found
that 248 (19%) and 393 (30%) proteins out of 1304 were
encoded by genes showing transcriptional upregulation in
day 0 or day 10 oocysts, respectively (Figure 3B). At day 0,
only 4.8% of upregulated genes exhibited a rise of mRNA
levels greater than 10-fold, with a maximum increment of
18.6-fold, whereas the vast majority (74%) showed a tran-
scriptional increase of only 2- to 5-fold. This unequal distri-
bution may reflect the fact that a significant fraction of
these genes have a transcriptional peak in developmental
stages preceeding the unsporulated oocyst, e.g., the macro-
gamete or the early zygote. Quite distinctly, ~41% of the
genes upregulated in fully sporulated oocysts showed
trancriptional increments higher than 10-fold, with 33
genes exhibiting fold increase values >100, e.g., the dense
granule proteins GRA7 (933) and GRA1 (810), the
microneme protein MIC11 (443) and the surface antigen
SRS57 (367).
Based on the assignment to MIPS functional categories,
the proteins encoded by genes upregulated in day 0 versus
day 10 oocysts showed a higher relative abundance of
molecules implicated in metabolism (16.5% versus 5.3%),
cellular transport (12.5% versus 3.6%) and protein fate
(15.3% versus 6.9%) (Figure 3C). On the other hand, genes
upregulated at day 10 encoded higher proportions of mol-
ecules involved in protein synthesis (10.4% versus 4.8%)
and in cell rescue, defence and virulence (15.0% versus
3.6%), with the latter group consisting mainly of proteins
located in secretory organelles [35], i.e., the rhoptries (39),
the micronemes (16) and the dense granules (8).
Putative oocyst/sporozoite-specific proteins (POSPs)
During the preparation of this manuscript, a considerable
number of novel proteomic identifications was added to
the release 7.1 of ToxoDB, including phosphoproteomic
and total proteomic data on intracellular and extracellular
tachyzoites [18,19] and the results of a global analysis of
oocyst proteins fractionated into wall and sporocyst/
sporozoite components [25]. Despite a marked cross-
contamination of the analysed fractions, the latter ap-
proach led to the identification of 1031 proteins, 794 of
which (77%) are represented in our dataset (Figure 4A). In
addition, the proteins identified in the present study were
filtered against the expressed tachyzoite proteome, which
consisted of 5325 proteins resulting from the combination
of global and subcellular proteomic data deposited in
ToxoDB by various laboratories. As shown in Figure 4A,
the oocyst/sporozoite dataset showed an overlap of ~88%with that of the tachyzoite and contained 154 proteins
devoid of proteomic evidence in this stage. Given the nu-
merous proteomic studies carried out on the tachyzoite
and the consequent extensive coverage of its expressed
proteome, these 154 unique proteins were likely to reflect
developmentally regulated expression and were referred to
as putative oocyst/sporozoite-specific proteins (POSPs)
(Table 1). The stage specificity of three POSPs was tested
by western blot using polyclonal antibodies raised against
the LCCL domain-containing proteins TGME49_056040
and TGME49_067410 and the tyrosine-rich hypothetical
protein TGME49_119890. As shown in Figure 4B, on
protein lysates of partially sporulated VEG oocysts all anti-
bodies yielded specific banding patterns compatible with
the predicted molecular masses of the selected proteins,
whereas no reactivity was observed on total tachyzoite ex-
tracts of the same parasite strain.
Functional role of molecules belonging to the POSP
subset
Compared to the whole oocyst/sporozoite dataset, the
POSP class exhibited a significant overrepresentation of
hypothetical proteins (45% versus 35%), probably reflecting
a defect in the annotation of oocyst/sporozoite proteins
caused by the paucity of molecular studies on this parasite
stage. Seventy-two out of 154 POSP (47%) were assigned a
MIPS functional category, with proteins involved in metab-
olism (28) constituting the largest class, followed by mole-
cules implicated in cell rescue, defence and virulence (17),
energy production (12) and protein fate (11).
Central carbon metabolism
Our proteomic analysis showed that T. gondii oocysts ex-
press the entire enzymatic complements involved in gly-
colysis/gluconeogenesis and the tricarboxylic acid (TCA)
cycle, the two main components of the central carbon me-
tabolism of living organisms. Interestingly, VEG oocysts
differed from tachyzoites for the abundant expression of
two enolase isoforms, ENO1 and ENO2 [36]. So far, these
two glycolytic enzymes were shown to be expressed in a
mutually exclusive, stage-specific fashion in bradyzoites
and tachyzoites, respectively, with only minimal amounts
of ENO1 detected in tachyzoites by two proteomic studies
[13,20]. While abundantly represented in our dataset,
ENO1 was not identified in fully sporulated M4 oocysts
[25], strongly suggesting that the expression of this
bradyzoite-type enolase is developmentally regulated dur-
ing oocyst maturation and is most likely specific to
the unsporulated form. Also the TCA cycle comprises
reactions catalyzed by two enzyme isoforms, e.g., isocitrate
dehydrogenase (TGME49_066760, TGME49_113140)
and succinate dehydrogenase (TGME49_015280, TGME-
49_015590), which were all detected by proteomics in
both tachyzoites and VEG oocysts. In addition, our
Figure 4 Identification and validation of putative oocyst/sporozoite-specific proteins (POSPs). (A) Comparison of the oocyst proteins
identified in the present study with the expressed proteome of the tachyzoite and a dataset of proteomically identified proteins of sporulated M4
oocysts [25]. Numbers in brackets indicate the complexity of each dataset. The Venn diagram shows the presence in the VEG oocyst dataset of
154 proteins (POSPs), indicated by the asterisk, lacking proteomic evidence in tachyzoites. (B) Western blot analysis of total protein extracts from
partially sporulated oocysts and tachyzoites of the VEG strain. The three panels show the reactivity of mouse polyclonal antibodies raised against
three members of the POSP subset, i.e., the tyrosine-rich hypotetical protein TGME49_119890 and the LCCL domain-containing proteins
TGME49_056040 and TGME49_067410. As quality and loading control, the tachyzoite lanes were also probed with an anti-SAG1 monoclonal
antibody (arrowhead). O, oocyst; T, tachyzoite.
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of citrate synthase, TGME49_068890, detected also in
tachyzoites and TGME49_003110, which is specific to
the oocyst stage. Citrate synthase is a rate-determining
enzyme converting oxaloacetate into citrate in the first
step of the TCA cycle, therefore, the stage-specific expres-
sion of a second isoform may have important regulatory
effects during oocyst development. Likewise, we found
that the oocyst possesses two 50% identical isoforms of
phosphoenolpyruvate carboxykinase, which provides a
crucial link between the TCA cycle and gluconeogenesis
by transforming oxaloacetate into phosphoenolpyruvate.
One of the two isoforms, TGME49_089930, was uniquely
identified in the oocyst and is encoded by a gene showing
30-fold transcriptional increase in unsporulated oocysts
compared to tachyzoites. This enzyme might fuel the
gluconeogenetic pathway and the eventual production of
amylopectin [37], which represents an important energy
source for sporulating oocysts and sporozoites.
Amino acid metabolism
The POSP subset included key enzymes for the synthesis
of 6 non essential amino acids of T. gondii, i.e., proline
(TGME49_069110), alanine (TGME49_115260, TGME-
49_003500), threonine (TGME49_016640), cysteine (TG-
ME49_059180, TGME49_078910, TGME49_112930),
lysine (TGME49_005420) and tyrosine (TGME49_08-
7510, TGME49_012740). The two forms of alaninedehydrogenase (EC 1.4.1.1), which catalyses the unidirec-
tional conversion of pyruvate into L-alanine, share 39%
sequence identity and differ for their predicted subcel-
lular localization, cytoplasmic for TGME49_115260
and mitochondrial for TGME49_003500. We detected
also two 98% identical isoforms of tyrosine hydroxylase
(TGME49_087510, TGME49_012740) possessing a bifunc-
tional activity able to catabolize phenylalanine to tyrosine
and tyrosine to 3,4-dihydroxy- L-phenylalanine (L-DOPA)
[38]. The presence of these two enzymes in the oocyst stage
may be important not only for de novo tyrosine synthesis,
but also for the supply of L-DOPA, which was shown to be
a component of the oocyst wall of Eimeria maxima [39],
an avian coccidian parasite related to T. gondii. The oocyst
differs from the tachyzoite also for the expression of three
distinct enzymes involved in the biosynthesis of cysteine.
This important amino acid can be produced either from
L-serine, through the successive action of cystathionine β-
synthase (TGME49_059180) and cystathionine β-lyase
(TGME49_112930), or from O-acetylserine, through the
fixation of inorganic sulphide by a plant/bacterial-like O-
acetylserine (thiol) lyase (TGME49_078910). In contrast
with previous views, current genomic data indicate that
T. gondii is not a threonine auxotroph but has the poten-
tial to synthesize this amino acid using homoserine as pre-
cursor. Our data showed that a predicted enzyme linked
to this pathway, homoserine kinase (TGME49_016640), is
indeed expressed in the oocyst stage.
Table 1 List of putative oocyst/sporozoite-specific proteins (POSPs) identified in this study

















TGME49_026300 oxidoreductase, putative 1.3.1.34 fatty acid β-oxidation 260 40 103 6.23E-11
TGME49_034570 peroxisomal multifunctional enzyme type 2,
putative
1.1.1.35 fatty acid β-oxidation 108 12 17 2.22E-16
TGME49_042390 enoyl-CoA hydratase/isomerase family protein,
putative
4.2.1.17 fatty acid β-oxidation 21 16 5 1.35E-12
TGME49_047500 acyl-coenzyme A oxidase, putative 1.3.3.36 fatty acid β-oxidation 92 37 49 6.76E-12
TGME49_066270 2-methylbutyryl-CoA dehydrogenase, putative 1.3.99.- fatty acid β-oxidation 7 <2 <2 1.00E-30
TGME49_115480 acyl-CoA oxidase, putative 1.3.3.36 fatty acid β-oxidation 183 71 151 1.91E-10
TGME49_032580 acetyl-coenzyme A synthetase, putative 6.2.1.1 glycolysis/gluconeogenesis 43 5 12 1.00E-30
TGME49_089930 phosphoenolpyruvate carboxykinase, putative 4.1.1.49 glycolysis/gluconeogenesis 30 3 6 8.70E-07
TGME49_016090 tropomyosin 1 alpha chain, putative - regulation of actin mechanics 247 11 19 5.66E-06
TGME49_027050 pyruvate dehydrogenase kinase, putative 2.7.11.2 regulation of pyruvate
dehydrogenase
3 4 3 2.16E-07




5 254 26 1.11E-15
TGME49_003110 citrate synthase, putative 2.3.3.1 TCA cycle 35 5 7 6.32E-09
metabolism
TGME49_003340 alkyl sulfatase, putative 3.5.2.6 - 8 <2 2 2.10E-05
TGME49_003580 NAD-binding domain-containing protein - - n.a. n.a. n.a. 4.73E-12
TGME49_038200 alpha/beta hydrolase fold domain containing
protein
- - 27 3 4 7.77E-15
TGME49_065860 nit protein 2, putative - - 5 <2 <2 2.74E-11
TGME49_069120 oxidoreductase, putative 1.1.1.100 - 183 61 125 4.44E-16
TGME49_069400 short chain dehydrogenase/reductase domain-
containing protein
1.1.1.100 - 11 <2 <2 2.42E-07
TGME49_106450 short chain dehydrogenase family protein,
putative
1.1.1.100 - <2 222 82 6.97E-05
TGME49_111780 alcohol dehydrogenase class III, putative 1.1.1.284 - 4 <2 <2 4.61E-06
TGME49_003500 alanine dehydrogenase, putative 1.4.1.1 amino acid metabolism 6 29 4 1.11E-15
TGME49_005420 aspartate-semialdehyde dehydrogenase, putative 1.2.1.11 amino acid metabolism 4 <2 <2 2.44E-08
TGME49_016640 homoserine kinase, putative 2.7.1.39 amino acid metabolism 74 28 26 4.03E-12
TGME49_059180 cystathionine beta-synthase, putative 4.2.1.22 amino acid metabolism n.a. n.a. n.a. 8.37E-13
TGME49_069110 ornithine aminotransferase, putative 2.6.1.13 amino acid metabolism 394 123 247 2.54E-12
TGME49_078910 O-acetylserine (thiol) lyase, putative 2.5.1.47 amino acid metabolism 20 3 5 2.39E-10
TGME49_112930 cystathionine beta-lyase, putative 4.4.1.1 amino acid metabolism 23 2 3 2.90E-10
TGME49_115260 alanine dehydrogenase, putative 1.4.1.1 amino acid metabolism 98 211 331 2.89E-14
TGME49_019230 acetoacetyl-CoA synthetase, putative 6.2.1.16 butanoate metabolism <2 <2 <2 4.97E-10
TGME49_031900 acyl-CoA dehydrogenase, putative 1.3.99.7 fatty acid metabolism 31 32 21 6.51E-11
TGME49_003570 acyltransferase, putative 2.3.1.15 glycerophospholipid
metabolism
2 <2 <2 3.08E-13
TGME49_010260 glycerol-3-phosphate dehydrogenase, putative 1.1.1.8 glycerophospholipid
metabolism
188 14 32 6.84E-13
TGME49_082230 sulfate adenylyltransferas-adenylylsulfate kinase,
putative
2.7.7.4 purine metabolism 52 5 10 7.38E-13
TGME49_107030 purine nucleoside phosphorylase 2.4.2.3 pyrimidine salvage pathway 12 2 3 1.11E-16
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Table 1 List of putative oocyst/sporozoite-specific proteins (POSPs) identified in this study (Continued)




9 21 23 1.63E-08
TGME49_002140 methylglutaconyl-CoA hydratase, putative 4.2.1.18 valine, leucine and isoleucine
degradation
5 2 2 1.02E-06
TGME49_005430 isovaleryl-CoA dehydrogenase, putative 1.3.99.10 valine, leucine and isoleucine
degradation
8 13 6 2.49E-10
TGME49_015250 thiamin pyrophosphokinase, putative 2.7.6.2 vitamin biosynthesis <2 <2 <2 1.03E-09
cell rescue, defence and virulence
TGME49_005660 F5/8 type C domain-containing protein (CCp1A) - - 114 11 14 1.00E-30
TGME49_023480 thrombospondin type 1 domain-containing
protein
- - 24 <2 <2 6.35E-07
TGME49_056040 LCCL domain-containing protein (CCp5B) - - 343 24 32 1.11E-15
TGME49_058370 Rhoptry kinase family protein ROP28 - - <2 46 23 2.51E-12
TGME49_063410 scavenger receptor protein TgSR2 - - 144 12 12 2.22E-15
TGME49_064070 antigenic protein, putative (CCp1B) - - 76 7 8 1.10E-10
TGME49_067410 scavenger receptor protein TgSR1 - - 306 26 29 2.21E-08
TGME49_027150 glutaredoxin, putative - detoxification of oxygen
radicals
−3 −3 −3 6.84E-05
TGME49_116190 superoxide dismutase, putative 1.15.1.1 detoxification of oxygen
radicals
<2 589 470 3.76E-12
TGME49_009920 PAN domain-containing protein - host cell attachment/invasion <2 557 142 2.33E-14
TGME49_032400 PAN domain-containing protein - host cell attachment/invasion <2 44 8 7.77E-15
TGME49_038460 SRS22B - host cell attachment/invasion <2 <2 <2 8.95E-05
TGME49_058550 SRS28 (SporoSAG) - host cell attachment/invasion 2 323 312 1.44E-14
TGME49_058810 SRS27B - host cell attachment/invasion <2 153 46 4.84E-09
TGME49_065120 hypothetical protein, conserved (RON2 iso2) - moving junction formation <2 28 13 8.17E-08
TGME49_094400 hypothetical protein (RON2 iso 1) - moving junction formation n.a. n.a. n.a. 5.89E-06
TGME49_115730 apical membrane antigen, putative (AMA1 iso1) - moving junction formation <2 16 4 4.98E-12
cell cycle and DNA processing
TGME49_006400 DNA photolyase, putative 4.1.99.3 DNA repair 34 252 99 1.82E-10
protein fate
TGME49_016150 oligoendopeptidase F, putative - - 213 25 52 1.21E-11
TGME49_031060 subtilase family serine protease, putative 3.4.21.66 - <2 2 <2 3.95E-07
TGME49_034950 protein kinase (incomplete catalytic triad) - - <2 2 5 2.22E-15
TGME49_044620 NEK kinase 2.7.12.2 - 2 <2 <2 1.11E-10
TGME49_046800 acylamino-acid-releasing enzyme, putative 3.4.19.1 - <2 −2 <2 2.10E-10
TGME49_047240 ubiquitin carboxyl-terminal hydrolase isozyme
L5, putative
3.4.19.12 deubiquitination pathway 3 −2 <2 7.70E-11
TGME49_066780 protein kinase (incomplete catalytic triad) - - 3 <2 <2 4.22E-14
TGME49_089240 DnaJ domain-containing protein 1.3.1.38 - <2 <2 <2 4.52E-11
TGME49_095640 endothelin-converting enzyme, putative 3.4.24.71 - 27 3 4 3.79E-12
TGME49_107640 CMGC kinase, CK2 family 2.7.12.2 - 140 19 27 2.15E-12
TGVEG_058750 protein kinase domain-containing protein,
putative
2.7.11.11 - n.a. n.a. n.a. 8.47E-07
cellular transport, transport facilities and transport routes
TGME49_065230 electron transfer flavoprotein-ubiquinone
oxidoreductase, putative
1.5.5.1 - 8 3 3 1.13E-12
TGME49_114330 ABC transporter, putative 3.6.3.44 - 31 13 12 9.50E-05
protein synthesis
TGME49_020300 ribosomal protein L15, putative - translation <2 <2 <2 9.08E-05
biogenesis of cellular components
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Table 1 List of putative oocyst/sporozoite-specific proteins (POSPs) identified in this study (Continued)
TGME49_043720 peroxisomal biogenesis factor 11 domain-
containing protein
- peroxisome fission 15 22 20 1.25E-05
TGME49_086250 oocyst wall protein, putative (OWP6) - oocyst environmental
resistance
44 7 12 6.83E-10
other
TGGT1_064840 hypothetical protein - - n.a. n.a. n.a. 7.85E-08
TGGT1_071710 hypothetical protein, conserved - - n.a. n.a. n.a. 5.11E-12
TGGT1_090830 hypothetical protein, conserved - - n.a. n.a. n.a. 2.89E-05
TGGT1_099390 hypothetical protein, conserved - - n.a. n.a. n.a. 7.99E-14
TGGT1_122010 hypothetical protein, conserved - - n.a. n.a. n.a. 6.77E-14
TGGT1_122320 hypothetical protein, conserved - - n.a. n.a. n.a. 4.09E-13
TGME49_002100 hypothetical protein - - 847 425 583 1.36E-07
TGME49_002110 hypothetical protein - - 1163 321 751 7.05E-11
TGME49_003230 hypothetical protein - - 11 42 27 3.05E-09
TGME49_003890 hypothetical protein - - 29 150 77 1.80E-09
TGME49_007250 hypothetical protein - - 155 15 28 7.55E-07
TGME49_009470 hypothetical protein - - 476 63 155 7.17E-10
TGME49_009810 hypothetical protein - - <2 30 11 2.86E-12
TGME49_012030 hypothetical protein - - <2 9 5 8.40E-11
TGME49_016970 hypothetical protein, conserved - - −5 2 <2 1.44E-14
TGME49_020280 SCP-like domain-containing protein - - n.a. n.a. n.a. 1.00E-30
TGME49_023430 hypothetical protein - - <2 66 6 1.23E-09
TGME49_023830 fasciclin domain-containing protein - - n.a. n.a. n.a. 1.50E-08
TGME49_023900 hypothetical protein - - 4 <2 <2 4.63E-05
TGME49_025120 rRNA processing protein, putative - - n.a. n.a. n.a. 1.00E-09
TGME49_026230 hypothetical protein - - <2 21 21 3.78E-08
TGME49_028240 hypothetical protein - - <2 <2 <2 2.11E-13
TGME49_030530 hypothetical protein - - 220 22 33 1.99E-10
TGME49_030540 hypothetical protein - - 53 6 10 4.33E-08
TGME49_031390 hypothetical protein - - 618 69 138 1.46E-09
TGME49_037080 hypothetical protein - - 1315 582 905 1.56E-10
TGME49_038160 hypothetical protein - - <2 252 78 1.03E-13
TGME49_038910 hypothetical protein - - n.a. n.a. n.a. 3.50E-05
TGME49_040610 hypothetical protein, conserved - - 65 5 3 3.57E-08
TGME49_044410 hypothetical protein - - n.a. n.a. n.a. 1.67E-07
TGME49_048170 hypothetical protein - - <2 4 2 3.33E-14
TGME49_048230 hypothetical protein - - <2 <2 <2 7.93E-05
TGME49_054760 hypothetical protein - - 153 126 80 1.12E-07
TGME49_055380 hypothetical protein - - 917 150 228 8.39E-12
TGME49_057690 hypothetical protein - - 16 3 3 2.10E-10
TGME49_058200 glutamic acid-rich protein, putative - - <2 48 31 6.43E-09
TGME49_058380 hypothetical protein - - <2 <2 <2 6.17E-05
TGME49_059670 von Willebrand factor type A domain-containing
protein
- - <2 257 41 2.22E-15
TGME49_062470 beta antigen, putative - - 658 129 203 5.09E-05
TGME49_065130 hypothetical protein - - <2 <2 <2 3.30E-11
TGME49_067980 hypothetical protein - - <2 9 5 2.01E-07
TGME49_068880 hypothetical protein - - −19 −3 −4 3.51E-09
TGME49_069350 hypothetical protein - - <2 <2 <2 3.29E-11
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TGME49_070950 hypothetical protein - - 15 238 348 5.74E-08
TGME49_071490 hypothetical protein - - 198 148 282 6.91E-13
TGME49_073510 hypothetical protein - - <2 79 41 6.66E-15
TGME49_073670 hypothetical protein - - −2 <2 <2 3.79E-05
TGME49_073700 hypothetical protein - - 260 27 52 3.42E-08
TGME49_076860 late embryogenesis abundant domain-
containing protein
- - <2 556 390 2.22E-15
TGME49_076870 LEA1 protein, putative - - 8 497 146 2.03E-12
TGME49_078120 SCP-like extracellular domain-containing protein - - <2 96 66 5.81E-09
TGME49_078340 hypothetical protein - - 2 4 <2 6.67E-07
TGME49_079440 hypothetical protein, conserved - - 161 14 26 4.43E-09
TGME49_080430 hypothetical protein - - 1057 220 376 1.47E-07
TGME49_085690 notch (DSL) domain-containing protein - - 121 15 21 8.51E-12
TGME49_087840 hypothetical protein - - <2 <2 <2 3.00E-14
TGME49_088220 hypothetical protein - - 52 51 13 1.00E-30
TGME49_089740 hypothetical protein - - <2 −4 <2 3.44E-07
TGME49_090610 hypothetical protein - - 557 38 42 5.26E-08
TGME49_091840 hypothetical protein - - 260 15 26 1.00E-30
TGME49_093780 hypothetical protein - - −60 <2 <2 2.56E-06
TGME49_094600 hypothetical protein - - 15 506 557 3.19E-13
TGME49_097280 hypothetical protein, conserved - - <2 453 139 2.63E-13
TGME49_097410 hypothetical protein - - 187 31 72 1.38E-08
TGME49_106050 hypothetical protein - - 89 14 30 1.11E-15
TGME49_106500 hypothetical protein - - <2 <2 <2 6.28E-11
TGME49_109530 hypothetical protein - - <2 3 <2 1.96E-11
TGME49_109540 hypothetical protein - - <2 <2 <2 2.57E-10
TGME49_110160 piwi-PAZ domain-containing protein (TgAgo) - gene silencing 21 7 5 7.45E-12
TGME49_116890 hypothetical protein - - 46 5 9 5.18E-12
TGME49_119890 hypothetical protein - - −14 53 33 1.08E-09
TGME49_120280 hypothetical protein - - 3 16 12 7.52E-12
TGME49_120290 hypothetical protein - - 8 <2 <2 4.68E-11
TGME49_120500 patched transmembrane domain-containing
protein
- - 12 <2 <2 1.37E-07
TGME49_120710 hypothetical protein - - <2 9 4 2.15E-07
TGVEG_029770 hypothetical protein - - n.a. n.a. n.a. 6.87E-06
TGVEG_051660 hypothetical protein, conserved - - n.a. n.a. n.a. 8.83E-13
TGVEG_058740 hypothetical protein, conserved - - n.a. n.a. n.a. 2.22E-16
TGVEG_060360 hypothetical protein - - n.a. n.a. n.a. 1.28E-11
TGVEG_095590 hypothetical protein - - n.a. n.a. n.a. 3.27E-11
aFold change values refer to differences between the mRNA levels of unsporulated (day 0) or sporulated (day 4 and day 10) oocysts compared to day 2 in vitro
tachyzoites of strain M4 [34].
Negative values indicate a downregulation in oocysts with respect to tachyzoites. Peak fold change values ≥2 are bolded. n.a., not available.
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The analysis of the POSP subset revealed that also the deg-
radation pathway of the branched amino acids valine, leu-
cine and isoleucine, which represents an important source
of acetyl-CoA, is more extensively covered in the oocyst
than in the tachyzoite. Two POSPs mapping to this mito-
chondrial pathway correspond to enzymes specificallyinvolved in leucine degradation, i.e., isovaleryl-CoA de-
hydrogenase (TGME49_005430; EC 1.3.99.10) and methyl-
glutaconyl-CoA hydratase (TGME49_002140; EC 4.2.1.18),
whereas a third enzyme, 2-methylbutyryl-CoA dehydro-
genase (TGME49_066270), is common to the pathways
leading to valine and isoleucine degradation and fatty acid
β-oxidation.
Possenti et al. BMC Genomics 2013, 14:183 Page 11 of 18
http://www.biomedcentral.com/1471-2164/14/183Fatty acid metabolism
The POSPs include several enzymes implicated in fatty
acid degradation, also known as β-oxidation. This im-
portant energy-producing process consists of succes-
sive rounds of four reactions each, during which one
acetyl-CoA two-carbon unit is released at each cycle
from even-chain fatty acids. The acetyl-CoA generated
enters the TCA cycle, where it is further oxidized to fuel
ATP synthesis via oxidative phosphorylation. The genome of
T. gondii encodes all enzymes required for this process and
six of them are represented in the POSP subset, i.e., two
isoforms of acyl-CoA dehydrogenases (TGME49_047500,
TGME49_115480; EC 1.3.3.6), 2-methylbutyryl-CoA de-
hydrogenase (TGME-49_066270; EC 1.3.8.1), 2,3-enoyl-CoA
hydratase (TGME49_042390; EC 4.2.1.17), 3-hydroxyacyl;-
CoA dehydrogenase (TGME49_034570; EC 1.1.1.35) and
2,4-dienoyl-CoA reductase (TGME49_026300; EC 1.3.1.34).
Interestingly, four of these enzymes share the presence of a
peroxisomal targeting signal, including TGME49_047500,
TGME-49_042390 and TGME49_034570, which catalyse
the first three reactions of the β-oxidation cycle, respectively,
and TGME49_026300, which plays an auxiliary role in the
degradation of unsaturated fatty acids in animal peroxi-
somes. Beside the peroxisomal TGME49_047500 men-
tioned above, two additional POSPs belong to the class of
FAD-dependent acyl-CoA dehydrogenases involved in
the first step of β-oxidation, i.e., TGME49_115480 and
TGME-49_066270. The two enzymes lack obvious organ-
elle targeting signals and show substrate preference for
medium- and short-chain fatty acids, respectively. Overall,
these results indicate that, unlike tachyzoites, T. gondii oo-
cysts rely on fatty acid breakdown to fuel the TCA cycle
through the production of acetyl-CoA. Furthermore, the
profile of β-oxidation proteins identified strongly suggests
that, like in mammals, also in T. gondii this process takes
place in both the peroxisomes and the mitochondria, with
the two compartments being presumably involved in the
degradation of very long- and medium/short-chain fatty
acids, respectively.
Amylopectin metabolism
Like other apicomplexan parasites forming environmentally
resistant oocysts, e.g., Eimeria spp. and Cryptosporidium
spp., T. gondii stores glucose in cytoplasmic granules
of amylopectin, a polysaccharide consisting of long
linear chains of glucose units linked by α-1,4-glycosidic
bonds, with occasiona1α-1,6-glycosidic bonds providing a
branching point [37]. While virtually absent in tachyzoites,
amylopectin is abundant in unsporulated oocysts, sporozo-
ites and bradyzoites [40], which use it as energy source.
Amylopectin degradation in T. gondii depends on the phos-
phorylase TGME49_110670 (EC 2.4.1.1), identified by prote-
omics in both oocysts and tachyzoites, which liberates
monomers of glucose-1-phosphate by cleaving α-1,4-glycosidic bonds up to four glucose residues from a
branching point. At this stage, further glucose mobilization
requires a debranching step, provided by glucanotransferase
(EC 2.4.1.25) and glucosidase (EC 3.2.1.33) activities. The
former transfers three glucose residues from a four-residue
amylopectin branch to a nearby α-1,4 chain, whereas the
second cleaves the remaining α-1,6 linkage, producing a glu-
cose unit. These two activities are provided by bifunctional
debranching enzymes in mammals and yeast and by two dis-
tinct enzymes in most bacteria. We found that T. gondii oo-
cysts share with tachyzoites the bifunctional debranching
enzyme TGME49_026910, but uniquely express a bacterial-
like 4-α-glucanotransferase (TGME-49_071210), whose
cognate microarray mRNA levels are 254-fold higher in day
4 oocysts than in tachyzoites. The stage-specific expression
of this enzyme has the potential to increase the rate of
amylopectin debranching and glucose mobilization,
supporting the extraordinary oocyst’s energy demand asso-
ciated with the sporulation process.
Purine metabolism
Two enzymes linked to purine metabolism were identified
exclusively in the oocyst. The first is purine nucleoside
phosphorylase (PNP) (TGME49_107030), which converts
exogenously acquired inosine and guanosine into hypo-
xanthine and guanine, respectively, thus providing a
source of nucleobases for the synthesis of purine nucleo-
tides. In accordance with the strict dependence of
T. gondii on external supplies of purine nucleobases
and nucleosides, the expression of PNP is likely an
adaptative response maximising the incorporation of pu-
rines salvaged from the host cell before oocyst shedding.
The second enzyme related to purine metabolism is the
bifunctional sulfate adenylyltransferase-adenylylsulfate
kinase (TGME49_082230), which catalyses the fixation of
inorganic sulfate into the sulfuryl group donor molecule
3’-phosphoadenylyl-sulfate.
Glycerophospholipid and vitamin metabolism
Two members of the POSP subset are related to
glycerophospholipid metabolism. The first protein (TGME-
49_010260) is a glycerol-3-phosphate dehydrogenase, one
of the key enzymes of the glycerol phosphate shuttle system
for the electron transport across the mitochondrial mem-
brane. Interestingly, this molecule appears to be a stage-
specific variant of TGME49_107570, a closely related
form of glycerol-3-phosphate dehydrogenase expressed in
tachyzoites and not identified in the present study. Like-
wise, TGME49_003570 is a putative glycerol-3-phosphate
acyltransferase distantly related to a second form of the en-
zyme so far identified only in tachyzoites. Concerning vita-
min biosynthesis, two enzymes lacking proteomic evidence
in tachyzoites were identified, i.e., thiamin pyrophos-
phokinase (TGME49_015250), which converts host-derived
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the subunit 1 (TGME49_003720) of the enzyme complex
vitamin K epoxide reductase, which is responsible for the
production of the co-factor vitamin K hydroquinone.
Cell rescue, defence and virulence
This relatively heterogeneous functional category is well
represented in the POSP subset and includes proteins im-
plicated in host cell attachment/invasion (10), components
of the parasite antioxidant system (2) and members of the
LCCL family (5). Proteins of the attachment/invasion sub-
group include the rhoptry kinase family [41] protein
ROP28 and 3 members of the SRS superfamily [27], i.e.,
SRS22B, SRS27B and the major sporozoite surface antigen
SRS28 (SporoSAG) [9]. Additionally, our analysis identified
a thrombospondin-related (TGME49_023480) and 2 PAN
domain-containing (TGME49_009920, TGME49_032400)
proteins showing domain architectures resembling
those of known micronemal adhesins of T. gondii. Inter-
estingly, invasion-related POSPs include also paralogous
versions of the mutually interacting MJ proteins AMA1
[42] and RON2 [43,44], denominated AMA1 iso1
(TGME49_115730), RON2 iso1 (TGME49_094400) and
RON2 iso2 (TGME49_065120) [45]. Recently, a crystallo-
graphic analysis mapped the AMA1-binding site of RON2
to a C-terminal sequence comprised between two closely
spaced transmembrane domains [46]. The alignment of
this amino acid sequence with the equivalent regions of
the RON2 paralogs (Figure 5) revealed a higher similarity
to RON2 iso2 and the conservation in this protein of 4
amino acid residues crucial for AMA1-RON2 interaction.
The co-expression of 2 AMA1 and 3 RON2 isoforms rep-
resents a very distinctive trait of sporozoites which, com-
pared to tachyzoites, seem to have the potential to
assemble different MJ types.
Previous studies [47,48] revealed the presence in
T. gondii of an elaborated antioxidant network based on
cytosolic, mitochondrial and apicoplast enzymes impli-
cated in the detoxification of oxygen radicals. Our analysis
identified 2 members of this network lacking tachyzoite
proteomic evidence, i.e., the mitochondrial superoxide
dismutase SOD3 (TGME49_116190) and a putative
glutaredoxin (TGME49_027150). While the mRNA levels
of the SOD3 gene are 470-fold higher in sporulated
oocysts compared to thachyzoites, the gene encoding
glutaredoxin TGME49_027150 appears to be equally
expressed in all stages.
The third class of molecules lacking proteomic evidence in
the tachyzoite consists of five proteins (TGME-49_005660,
TGME49_064070, TGME49_056040, TGME-49_067410 and
TGME49_063410) belonging to the so-called LCCL family,
which is exclusive, among protozoan parasites, of the api-
complexa. In T. gondii this group of multi-modular proteins
is composed by 7 members containing one or more copiesof the LCCL domain (F. Spano, unpublished). Although the
function of this protein class in T. gondii remains unknown,
there is evidence that the plasmodial orthologs have a sexual
stage-specific expression and are involved in oocyst/sporozo-
ite maturation [49].
Proteins belonging to other MIPS functional categories
Other functionally heterogeneous members of the POSP
subset appear particularly relevant to oocyst biology.
One example is the DNA photolyase TGME49_006400,
an evolutionarily conserved enzyme that repairs DNA
damage, i.e., pyrimidine dimers, caused by the exposure to
ultraviolet light. The stage-specificity of this enzyme is
consistent with the oocyst need to resist various environ-
mental stresses, including ultraviolet radiation. Accord-
ingly, the DNA photholyase transcript is 30–100 fold
more abundant throughout oocyst maturation compared
to tachyzoites and bradyzoites. Another protein strictly re-
lated to oocyst resistance is the oocyst wall protein 6
(TgOWP6; TGME49_086250). As we showed previously
[10], TgOWP6 belongs to a family of seven structurally re-
lated cysteine-rich proteins named TgOWP1-7. Using spe-
cific antibodies, TgOWP1-3 were shown to be abundantly
expressed in the oocyst wall of T. gondii [10], yet in the
present study TgOWP6 was the only member of this pro-
tein class to be identified, probably reflecting difficulties in
solubilizing TgOWPs’ monomers engaged in multimeric
complexes.Discussion
We reported herein on the identification by mass
spectrometry of 1615 proteins expressed in the oocyst
of T. gondii, a developmental stage which has been
scarcely characterized at the molecular level, despite
its fundamental role in disease transmission. The
present work adds to a very recently published prote-
omic analysis of T. gondii oocysts of strain M4 [25].
Both studies employed 1-D gel electrophoresis LC
MS-MS, yet they differed for the parasite strain
analysed, i.e., VEG (genotype III) versus M4 (genotype
II), for the modality of protein extraction and frac-
tionation, and principally for the maturation stage of
the oocyst samples, which consisted of partially or
fully sporulated oocysts, respectively. While the pres-
ence in our sample of both unsporulated and sporu-
lated oocysts hampered the association of protein
expression with a well defined oocyst maturation
stage, it enabled the proteomic sampling of a wider
range of proteins, including those expressed exclu-
sively, or more abundantly, prior to sporulation. Ex-
cluding the proteins identified with a single peptide
in just one experiment, the VEG oocyst dataset
exceeded that of strain M4 by 510 proteins, of which
Figure 5 Amino acid sequence variability in the AMA1-binding site of RON2 paralogs. The amino acid sequence of the AMA1-binding site
of TgRON2 (red bar) was aligned with the corresponding regions of TgRON2 iso1 (TGME49_094400) and TgRON2 iso2 (TGME49_065120). The C-
terminal transmembrane domains (TMD2 and TMD3) of the three paralogs are highlighted in grey. Conserved amino acids within the AMA1-
binding sequence are framed in black, those lying in the flanking regions are bolded. Asterisks indicate RON2 amino acid residues playing a
crucial role in AMA1 binding [46].
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were identified here for the first time.
Although the coverage of the oocyst proteome provided
by our analysis could not be determined, the considerable
size of the produced dataset offered a representative view of
the protein complement expressed during oocyst develop-
ment and sporozoite differentiation. One of the major im-
plications of the present study was to shed light for the first
time on the metabolic organization of the oocyst/sporozo-
ite, unveiling stage-specific differences with respect to the
extensively studied tachyzoite. Numerous metabolic routes
were identified underlying the metabolism of a wide range
of molecules, including lipids, carbohydrates, amino acids,
nucleotides and vitamins. Consistent with the resolution
limit inherent to a single-platform, global proteomic ana-
lysis and considering that protein expression levels may
range across many orders of magnitude, several metabolic
pathways were not entirely covered by our study. This im-
plies that establishing the non functionality of a given meta-
bolic route in the oocyst will require a higher number of
identifications. Nevertheless, the absence from both VEG
and M4 [25] datasets of the entire enzymatic complements
specific of isoprenoids (8 enzymes) and shikimate (5 en-
zymes) biosynthesis suggests that in the oocyst these path-
ways may be markedly downregulated or missing.
We found that T. gondii oocysts possess the full comple-
ment of both glycolytic and TCA cycle enzymes, differing
from tachyzoites for the expression of alternative isoen-
zymes of enolase (ENO1), citrate synthase and phospho-
enolpyruvate carboxykinase, which connects the two
pathways by fueling gluconeogenesis. The relative contribu-
tion of glycolysis and TCA cycle to energy production in
T. gondii is still an open issue. Previous works compared
the in vitro activity of select enzymes involved in either of
the two pathways, highlighting stage-specific differences be-
tween tachyzoites and bradyzoites. Biochemical data re-
vealed that in bradyzoites glycolysis largely predominates
over the TCA cycle, suggesting that this latent parasite
stage lacks a functional electron transport chain [50]. Con-
versely, tachyzoites rely on both pathways, with glycolysis
playing a major role in extracellular parasites by supplying
most of the energy required for gliding motility and inva-
sion [51,52], whereas oxidative phosphorylation isimportant for ATP homeostasis in intracellular tachyzoites
[53]. Importantly, there is evidence that in T. gondii and
Plasmodium spp. the TCA cycle is not coupled to glycoly-
sis, as the pyruvate dehydrogenase complex, which cataly-
ses pyruvate conversion into acetyl-CoA, is not typically
localized to the mitochondrion, but is specific to the
apicoplast [54,55]. This striking feature raises the question
as to how T. gondii generates the mitochondrial acetyl-CoA
to be fed into the TCA cycle. Our proteomic data indicated
a very plausible explanation, pointing to a major involve-
ment of two acetyl-CoA-producing pathways alternative to
glycolysis, i.e., the β-oxidation of fatty acids and the degrad-
ation of branched amino acids. In fact, we identified all en-
zymes of the fatty acid β-oxidation route and the majority
of those involved in the catabolism of valine, leucine and
isoleucine, with several enzymes of both pathways lacking
proteomic evidence in tachyzoites. The stage-specific usage
of these two mitochondrial pathways is consistent with the
peculiar biology of the oocyst, which must undergo the
energy-demanding process of sporulation and survive in
the environment for prolonged periods, without a continu-
ous supply of host-derived nutrients. As an alternative to
fatty acid and branched amino acid degradation, intracellu-
lar tachyzoites presumably fuel the TCA cycle using the en-
zyme acetyl-CoA synthetase (TGME49_066640), which
could produce acetyl-CoA from the acetate scavenged from
host cell mitochondria recruited to the parasitophorous
vacuole. Comparative genomic analysis showed that
apicomplexan parasites exhibit markedly different patterns
of amino acid auxotrophy, with T. gondii encoding a com-
plement of enzymes for the synthesis of 12 out of 20 amino
acids, as opposed to 6 in Plasmodium, 4 in Cryptosporid-
ium and 3 in Theileria [56]. We provided proteomic evi-
dence that the capacity of de novo amino acid biosynthesis
is developmentally modulated in T. gondii, with oocysts
showing a greater commitment than tachyzoites, a feature
that is in accordance with the long-term permanence of the
oocyst in the extracellular environment.
The vast majority of the protein identifications reported
herein were corroborated by mRNA expression data, 94%
of which were derived from microarray analysis of M4 oo-
cysts collected at day 0, 4 or 10 of sporulation [34]. In the
present study, we employed a heterogeneous preparation of
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comparison between VEG proteomic and M4 microarray
results was not feasible. However, 62 out of 1304 (4.7%)
VEG proteins were encoded by genes not exceeding the
25th microarray percentile in M4 oocysts at all three sporu-
lation time points. This evidence indicates that in our study
a significant, and probably underestimated, proportion of
proteins was successfully identified despite cognate mRNA
levels close to baseline. Regarding the POSP subset, we
found that of 134 proteins supported by microarray evi-
dence in strain M4, approximately 30% were either associ-
ated with mRNA levels differing by less than 2-fold
between oocysts and tachyzoites (9.7%) or encoded by
transcripts whose relative abundance in tachyzoites was el-
evated, being comprised between the 50th and the 100th
percentile (20.8%). These data are in evident contrast with
the absence of these proteins from the extensively covered
proteome expressed by the tachyzoite [32] and argue for
the existence in T. gondii of post-transcriptional control
mechanisms of protein expression, as already reported in
other protozoan parasites [57-59]. In accordance with this
hypothesis, we have previously shown that the genes
TgOWP1, TgOWP2 and TgOWP3 are transcribed in both
VEG oocysts and tachyzoites, yet the encoded oocyst wall
proteins are not expressed in the latters [10]. Sequence
analysis of RT-PCR products showed that tachyzoites dif-
fered from the oocyst for the presence of multiple mRNA
forms of TgOWP1-3 in which one or more introns were
retained, abolishing the coding potential of the immature
transcripts. The same phenomenon was observed also for
the SporoSAG gene (F. Spano, unpublished), pointing to
the inhibition of pre-mRNA splicing as one of the strat-
egies underlying stage-specific protein expression in T.
gondii.
The molecular bases of host cell invasion by the
sporozoite of T. gondii are virtually unknown, mostly
due to the difficulty of preparation and the transitory
nature of this infectious stage, which rapidly differenti-
ates into a tachyzoite inside the host cell. It can be rea-
sonably assumed that sporozoites and tachyzoites
utilize the same invasion machinery, yet there is evi-
dence that the formers express stage-specific invasion-
related proteins [9,25], exemplified here by SRS22B,
SRS27B, SRS28, ROP28 and by isoforms of AMA1 and
RON2. In addition, two of the POSPs identified,
TGME49_032400 and TGME49_009920 [60], are valid
MIC candidates, as they both possess a leader peptide
followed by tandem copies of the PAN domain, previ-
ously described in the microneme proteins TgMIC4 of
T. gondii [61] and EtMIC5 of Eimeria tenella [62].
Finally, it cannot be excluded that the POSP subset
contains other invasion-related proteins, whose identi-
fication may be hampered by the low degree of phylo-
genetic conservation typical of ROPs and GRAs.Conclusions
We have described the results of a global proteomic ana-
lysis of the oocyst/sporozoite of Toxoplasma gondii,
expanding significantly the coverage of the protein reper-
toire expressed by this important parasite stage. Using par-
tially sporulated oocysts of the genotype III strain VEG,
we generated a dataset of 1304 non reduntant proteins,
accounting for ~18% of the total predicted proteome.
Approximately 38% of the identifications corresponded
to hypothetical proteins, whereas ~59% were classified
according to the MIPS functional catalogue database. Im-
portantly, we identified 154 proteins lacking preoteomic
evidence in the extensively studied tachyzoite stage, which
are likely to represent oocyst/sporozoite-specific proteins
(POSPs). Their functional profile reflects the adaptation of
the oocyst of T. gondii to the nutrient-poor and stressing
extracellular environment, as shown by the preponderance
of enzymes involved in metabolism (28) and energy pro-
duction (12) or by the presence of a photolyase DNA re-
pair enzyme. Compared to tachyzoites, oocysts were
found to have a greater capability of de novo amino acid
biosynthesis and to rely on the degradation of fatty acids
and branched amino acids as sources of acetyl-CoA. In
addition, our data indicated that T. gondii sporozoites and
tachyzoites possess extensively overlapping repertoires of
invasion-related proteins, yet sporozoites express stage-
specific isoforms of AMA1 and RON2, two proteins es-
sential for moving junction formation and host cell inva-
sion. Finally, the comparison between proteomic and
microarray data showed that the stage-specific expression
of a significant fraction of the POSPs cannot be justified
by different mRNA levels in oocysts and tachyzoites,
suggesting the existence of post-transcriptional control
mechanisms. The present work shed light for the first time
on the metabolic organization of the oocyst of T. gondii
and represents a further step toward the understanding of
the fundamental biology of this important parasite stage.
A major goal of future proteomic studies should be the
elucidation of proteome dynamics during oocyst transition
from the unsporulated to the metabolically active, sporu-




Toxoplasma gondii oocysts of the VEG strain (genotype
III) were recovered from the feces of experimentally
infected cats housed at the United States Department of
Agriculture Laboratory, Beltsville, Maryland as described
[63]. All cats used in experiments were handled using
procedures approved by the Beltsville Area Animal Care
and Use Committee, United States Department of Agri-
culture, USA. Sporulation was induced by incubating the
oocysts in 2% sulfuric acid at room temperature for one
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lution at 4°C for prolonged storage. Oocyst were purified
by sucrose floatation as described previously [1] and suc-
cessively stored in 2% sulfuric acid. Tachyzoites of the
VEG strain were cultured in human foreskin fibroblasts
(HFF) in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% Nu-Serum (Gibco), 2 mM glutam-
ine, 10 mM HEPES (N-2-hydroxyethylpiperazine N’-2
-ethanesulfonic acid) and 20 μg/ml gentamicin.
Protein extraction
Purified T. gondii oocysts were treated with 10% sodium
hypochlorite for 20 min on ice, extensively washed with
PBS and ruptured by shaking on a vortex with 400–
600 μm glass beads (Sigma) for 5 min, to obtain free spo-
rocysts. Sporozoite excystation was induced by incubating
the broken oocysts with 1.5% sodium taurocholate at 37°C
for 40 min. Following PBS washings, the parasite material
was collected by centrifugation at 10000 g for 10 min and
further processed for protein extraction. To produce total
protein lysates (experiments 1 and 2), the parasite pellet
was resuspended in urea/thiourea buffer (7 M urea, 2 M
thiourea, 2% CHAPS, 1% ASB 1–14, 1% SB 1–12), freeze-
thawed three times, supplemented with 200 mM DTT/1%
SDS and shaked at 900 rpm for 3 h at 37°C. Following cen-
trifugation at 16000 g for 30 min at 4°C, the supernatant
was recovered and analysed by 1D gel electrophoresis LC
MS/MS. To produce fractionated lysates (experiment 3),
the parasite pellet was resuspended in 100 mM Tris–HCl
pH 8.5, supplemented with protease inhibitors and
200 mM DTT. The sample was freeze–thawed three times,
subjected to three cycles of 5 min in a water bath sonicator
and centrifuged at 16000 g for 30 min at 4°C, prior to col-
lection of the supernatant. The pellet was washed three
times with 100 mM Tris–HCl pH 8.5, containing protease
inhibitors, and the washings were pooled with the super-
natant constituting the soluble fraction. Next, the pellet
was resuspended in urea/thiourea buffer, freeze-thawed
three times, supplemented with 100 mM DTT/2% SDS,
subjected to three cycles of 5 min in a water bath sonicator
and incubated for 2 h at 37°C with shaking at 900 rpm. Fol-
lowing centrifugation at 16000 g for 30 min at 4°C, the
supernatant, representing the insoluble fraction, was col-
lected and analysed by 1D gel electrophoresis LC MS/MS
along with the soluble fraction. Tachyzoite proteins were
extracted in urea/thiourea buffer as mentioned above,
starting from VEG parasites released from infected HFF by
passage through a 27-gauge syringe needle and subse-
quently filtered through 3-μm pore diameter filters.
SDS-PAGE and in-gel digestion
From 50 to 75 μg of total protein extracts or soluble/insol-
uble protein fractions obtained from T. gondii oocysts
were resolved by SDS-PAGE on 10% precast minigels(NuPAGE Novex Bis-Tris; Invitrogen), loading the sam-
ples in 1.2 cm-wide wells. Following staining with NuPage
Colloidal Coomassie (Invitrogen), gel lanes were cut into
30 to 48 slices depending on protein band density. In-gel
tryptic digestion was performed as previously described
[64]. Briefly, gel slices were destained by washings in
acetonitrile (ACN)/25 mM NH4CO3 (vol/vol), treated
with 10 mM DTT (40 min at 56°C) and 55 mM
iodoacetamide (30 min in the dark at RT) to reduce and
alkylate cysteines, shrunken with ACN and rehydrated for
40 min on ice with a solution of 12,5 ng/μl trypsin
(Promega) in 50 mM NH4CO3. Next, the trypsin solution
was replaced with 25 mM NH4CO3 and protein digestion
was carried out overnight at 37°C. Supernatants from indi-
vidual gel slices were directly used for LC-MS/MS
analysis.
Liquid chromatography tandem mass spectrometry
Analysis by LC-MS/MS was performed using a nano-
HPLC 3000 Ultimate (Dionex) connected in line to
LTQ-XL linear ion trap (Thermo Fisher). Tryptic digests
(20 μl) were firstly loaded on a C18 RP-precolumn
(300 μm i.d.×5 mm; 5 μm particle size; 100 Å pore size;
LC Packings-Dionex) and washed by the loading pump
at 20 μl/min with buffer A (95% ACN, 0.1% FA) for
5 min and then by the micro pump at 0.3 μl/min on an
homemade 10 cm × 75 μm-i.d. Silica PicoTip (8 ±1 μm)
column (PicoTip Emitter, NewObjective) packed with
Magic C18AQ (5 μm particle size; 200 Å pore size,
Michrom Bioresources Inc.) for chromatographic separa-
tions. Peptides were eluted along a 50 min linear gradi-
ent from 4% to 50% of buffer B (95% ACN, 0.1 % FA)
and electrosprayed directly into the mass spectrometer
with a spray voltage of 1.65-1.75 kV and a capillary
temperature of 180°C.
Data acquisition was performed in data-dependent
mode to automatically switch between MS and MS2. Full-
scan MS parameters settings was: automatic gain control
value of 30000 ions; maximum injection time of 50 ms;
m/z 400–2000 mass range. The five most intense ions
were sequentially selected and fragmented in CID mode
with the following parameters settings: isolation width of
2.0; automatic gain control value of 10000 ions; maximum
injection time of 100 ms; m/z 50–2000 mass range; colli-
sion energy of 35%; minimum signal threshold of 200
counts; wide band activation on. A dynamic exclusion of
ions previously sequenced within 30 sec was applied.
Mass spectrometry data processing
Raw spectra were analysed by Bioworks Browser 3.3.1 using
the Sequest 3.1 search engine against an indexed database
containing all predicted tryptic peptides from T. gondii pro-
teins (ToxoDB release 5.1) [65]. Carboamidomethylation of
cysteines was specified as fixed modification and oxidation
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ance was set to 1 Da for precursor ion and ±0.4 Da for frag-
ment ions and a maximum of two missed cleavages was
allowed. The minima criteria for protein identification were:
peptide probability <1E-04; peptide XCorr vs charge = 1.5
for charge +1; 2 for charge +2; 2.5 for charge +3; 3 for
charge +3; FDR <1%.
Bioinformatics predictions
All proteins identified were assigned a subcellular
localization combining the results of the general predictor
WoLF PSORT (http://wolfpsort.org/) with those obtained
with the softwares PlaMit (http://gecco.org.chemie.uni-
frankfurt.de/plasmit/index.html), PATS (http://gecco.org.
chemie.uni-frankfurt.de/pats/pats-index.php) and PTS1
(http://mendel.imp.ac.at/mendeljsp/sat/pts1/) for the iden-
tification of mitochondrial, apicoplast and peroxisomal
targeting signals, respectively. Proteins were classified into
functional categories according to the MIPS functional
catalogue database (http://mips.helmholtz-muenchen.de/
proj/funcatDB/search_main_frame.html) based on GO
biological process annotations provided by ToxoDB, on
KEGG Pathway database (http://www.genome.jp/kegg/)
annotations and on BLASTP homology searches (http://
blast.ncbi.nlm.nih.gov/).
Production of recombinant proteins and western blot
analysis
Recombinant fragments of the LCCL domain-containing
proteins TGME49_056040 (amino acids 555–996) and
TGME49_067410 (amino acids 353–682) and of the
tyrosine-rich protein TGME49_119890 (amino acids 24–
193) were produced in Escherichia coli (strain M15) as fu-
sion products with an N-terminal tag of six histidines using
the expression plasmid pQE30 (Qiagen). The following
primers were used for PCR amplification of the target se-
quences from a T. gondii cDNA library of partially sporu-









G-30). The recombinant polypeptides were purified from
total bacterial lysates by nickel affinity chromatography
under denaturing conditions and successively dialysed
against multiple changes of PBS, pH 7.2. To raise mouse
antisera by intraperitoneal injection, BALB/c female mice
were immunized three times (at 3–4 week intervals) with
50 μg of purified recombinant protein in complete (first
immunization) or incomplete (first boost) Freund’sadjuvant. Individual sera were collected 2 weeks after the
second boost (soluble antigen in PBS). The animal work
has been authorized by the Italian Ministry of Health,
according to the Legislative Decree 116/92 which
implemented the European Directive 86/609/EEC on la-
boratory animal protection. Animals used in this study
were housed at the Istituto Superiore di Sanità and treated
according to Legislative Decree 116/92 guidelines.
Total protein extracts from VEG oocysts and tachyzoites
were quantified with a Qubit fluorometer (Invitrogen) and
equal amounts of the two samples were resolved by SDS–
PAGE on 10% NuPage Novex Bis–Tris gels (Invitrogen).
Following transfer to nitrocellulose, the blots were blocked
with 5% w/v skimmed milk in 1X Tris Borate Saline
Tween (TBST; 50 mM Tris pH 8.0, 150 mM NaCl, 1%
Tween 20) and probed for 1 h with the appropriate mouse
antiserum (1:1000) or with the anti-SAG1 mAb T41E5
(1:20000), kindly donated by J-F. Dubremetz, (University
of Montpellier, France). After 30 min incubation with a
goat anti-mouse IgG secondary antibody conjugated to
horseradish peroxidase (BioRad), reactive protein bands
were revealed by chemiluminescence with LiteAblot Plus
(EuroClone, Italy).
Additional files
Additional file 1: Figure S1. Electrophoretic profiles of fractionated
oocyst/sporozoite proteins of T. gondii. In experiment 3, Tris-soluble and
Tris-insoluble protein samples were resolved by SDS-PAGE on a 10%
acrylamide gel under reducing conditions and processed for LC-MS/MS
analysis. Protein bands were visualized by staining with colloidal
Coomassie. The arrows indicate the positions of representative gel slices.
Additional file 2: Table S1. Complete dataset of T. gondii oocyst/
sporozoite proteins identified in this study. The table includes the list of
the 1615 VEG oocyst proteins identified in the present study. Each
protein is identified by the gene ID (column A) and annotation (column
B) provided by ToxoDB 7.1. Columns C-E report Bioworks Browser 3.3.1
parameters, the number of peptides indicated in column E refers to the
best identification. Column F reports the number of experiments in
which each protein was identified. Column G indicates the predicted
molecular weight of full length polypeptides. Asterisks indicate two
proteins (TGGT1_064110 and TGGT1_064850) identified with a single
peptide shared by other T. gondii proteins, whose IDs and annotations
are reported at the bottom of the table.
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